PTH and hyperphosphatemia: Mineral bone disorder (MBD) is a common condition in patients with CKD at middle to advanced stages; it is characterized by hyperphosphatemia, hypocalcemia, and elevated levels of parathormone (PTH) and is associated with bone disease, vascular calcifications, and risk of all-cause and cardiovascular death [4].